Clinical significance and potential regulatory mechanism of overexpression of pituitary tumor-transforming gene transcription factor in bladder cancer
Abstract Background Pituitary tumor transforming gene-1 (PTTG1) transcription factor is identified as carcinogenic and associated with tumor invasiveness, but its role in bladder cancer (BLCA) remains obscure. This research is intended to analyze the aberrant expression and clinical significance of...
Main Authors: | Jian-Di Li, Abdirahman Ahmed Farah, Zhi-Guang Huang, Gao-Qiang Zhai, Rui-Gong Wang, Jia-Lin Liu, Qin-Jie Wang, Guan-Lan Zhang, Zi-Long Lei, Yi-Wu Dang, Sheng-Hua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-022-09810-y |
Similar Items
-
Comprehensive analysis of transferrin receptor (TFRC) as a prognostic biomarker for patients with bladder cancer
by: Zhiwei Jiang, et al.
Published: (2024-02-01) -
TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer
by: Runhua Tang, et al.
Published: (2024-02-01) -
Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma
by: Yonghui Gui, et al.
Published: (2021-04-01) -
Transmembrane protein 132A (TMEM132A) predicts overall survival for bladder cancer patients
by: Ruicheng Wu, et al.
Published: (2023-09-01) -
The Oncogenic Roles of <i>PTTG1</i> and <i>PTTG2</i> Genes and Pseudogene <i>PTTG3P</i> in Head and Neck Squamous Cell Carcinomas
by: Inga Grzechowiak, et al.
Published: (2020-08-01)